← Eichor
Condition: Lymphangioleiomyomatosis Lam Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Lymphangioleiomyomatosis Lam

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis
Phase 1/Phase 2 · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT01799538Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry)
Phase N/A · 1 location(s) · David M. Ritter · NCT06160310Evaluating the Long-term Safety and Tolerability of Imatinib in Patients With Lymphangioleiomyomatosis (LAM)
Phase 1 · 2 location(s) · Columbia University · NCT06889168Safety and Durability of Sirolimus for Treatment of LAM
Phase N/A · 20 location(s) · University of Cincinnati · NCT02432560The Genotype and Phenotype of Lymphangioleiomyomatosis
Phase N/A · 1 location(s) · National Taiwan University Hospital · NCT06405997Role of Extracellular Vesicles as Biomarkers of Pulmonary Involvement in Patients With Lymphangioleiomyomatosis and Tube
Phase N/A · 1 location(s) · University of Milan · NCT07304856TSC Biosample Repository and Natural History Database
Phase N/A · 26 location(s) · National Tuberous Sclerosis Association · NCT05676099National Lymphangioleiomyomatosis Registry, France
Phase N/A · 1 location(s) · Vincent COTTIN · NCT01484236Study of the Disease Process of Lymphangioleiomyomatosis
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT00001465A National Registry on Chinese Patients With Lymphangioleiomyomatosis
Phase N/A · 1 location(s) · Peking Union Medical College Hospital · NCT03193892
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.